Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | Clinical Trials in Pittsburgh | 10,713 Studies Near You

Clinical TrialsPittsburgh

Clinical Trials in Pittsburgh

Discover 10,713 clinical trials near Pittsburgh, Pennsylvania. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 5481-5500 of 10,713 trials

Active not recruitingSafety and Efficacy Study of reSept ASD Occluder for Treating Secundum ASDEvaluation of the safety and efficacy of the reSept ASD Occluder to treat patients with clinically significant secundum atrial septal defectNCT04591392·Birmingham, Alabama and 31 others

Find Trials by Condition in Pittsburgh

Breast Cancerin Pittsburgh Lung Cancerin Pittsburgh Prostate Cancerin Pittsburgh Colorectal Cancerin Pittsburgh Melanomain Pittsburgh Leukemiain Pittsburgh Lymphomain Pittsburgh Pancreatic Cancerin Pittsburgh Ovarian Cancerin Pittsburgh Brain Cancerin Pittsburgh

Data from ClinicalTrials.govTerms

RecruitingAutologous Stem Cell Transplantation in Patients With Systemic SclerosisThe purpose of this study is to determine whether a regimen of high-dose immunoablative therapy will demonstrate safety that is consistent or improved with other published…NCT03630211·Pittsburgh, Pennsylvania and 2 others

CompletedThe Glucagon Stimulation Test for Evaluation of Adult Growth Hormone Deficiency and Adrenocorticotropic AxisThe purpose of this study is to find out if the Glucagon Stimulation Test (GST) is a reliable alternative to the Insulin Tolerance Test (ITT) for diagnosis of Growth Hormone…NCT01282164·Boston, Massachusetts and 3 others

CompletedAn Efficacy, Safety, and Tolerability Study of Canagliflozin in the Treatment of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin MonotherapyThe purpose of this study is to evaluate the efficacy and safety of 2 different doses of canagliflozin compared with placebo in patients with type 2 diabetes mellitus who are…NCT01340664·Little Rock, Arkansas and 60 others

CompletedTrial of TRC105 and Pazopanib Versus Pazopanib Alone in Patients With Advanced AngiosarcomaThis is a study of TRC105 in combination with standard dose pazopanib compared to single agent pazopanib in patients with angiosarcoma not amenable to curative intent surgery…NCT02979899·Tucson, Arizona and 38 others

CompletedDose-ranging Study of PRX-102 in Adult Fabry Disease PatientsThis is the first human treatment with PRX-102, an enzyme being developed as a long-term enzyme replacement therapy in patients with a confirmed diagnosis of Fabry disease (alpha…NCT01678898·Sacramento, California and 13 others

RecruitingA Phase 1 Study of LNCB74 in Advanced Solid TumorsThis is an open-label, phase 1, dose escalation and dose expansion study to determine safety and tolerability, and to determine the maximum tolerated dose and / or recommended…NCT06774963·Newport Beach, California and 13 others

Active not recruitingAdjuvant Chemotherapy in Patients With Intermediate or High Risk Stage I or Stage IIA Non-squamous Non-Small Cell Lung Cancer: AIM-HIGH (Adjuvant Intervention in Molecular High Risk Patients)The optimal treatment for Stage I or Stage IIA non-small cell lung cancer (NSCLC) remains controversial.NCT01817192·Mission Viejo, California and 48 others

CompletedDoes Supplementing Vitamin D Deficiency Affect Fusion Healing Rates in Elective Foot and Ankle Surgery?To assess if vitamin D status in the elective foot and ankle fusion population affects fusion healing categorically (fused vs. un-fused).NCT04450199·Pittsburgh, Pennsylvania

CompletedVitamin D to Improve Outcomes by Leveraging Early TreatmentVitamin D deficiency is a common, potentially reversible contributor to morbidity and mortality among critically ill patients.NCT03096314·Fresno, California and 46 others

CompletedTreatment Efficacy and Toxicity in Rheumatoid Arthritis Database and RepositoryTo stimulate collaborative efforts of federal funding agencies, voluntary health agencies, professional organizations and industry partners to enable creation of a large…NCT01070121·Birmingham, Alabama and 8 others

TerminatedFulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung CancerThis research study will test whether dual anti-estrogen therapy (anastrozole and fulvestrant) slows the time to when the cancer progresses.NCT00932152·Pittsburgh, Pennsylvania

TerminatedMicrotubule-Targeted Agent BAL101553 and Radiation Therapy in Treating Patients With Newly Diagnosed GlioblastomaThis Phase I study investigated the side-effects and best dose of microtubule-targeted agent BAL101553 when given together with radiation therapy in treating patients with…NCT03250299·Birmingham, Alabama and 7 others

Active not recruitingBONAPH1DE, A Prospective Observational Study of Patients With Primary Hyperoxaluria Type 1 (PH1)The purpose of this study is to describe the natural history and progression of patients diagnosed with PH1, and to characterize the long-term real-world safety and effectiveness…NCT04982393·Phoenix, Arizona and 29 others

Active not recruitingCediranib Maleate and Olaparib Compared to Bevacizumab in Treating Patients With Recurrent GlioblastomaThis randomized phase II trial studies how well cediranib maleate and olaparib work compared to bevacizumab in treating patients with glioblastoma that has come back (recurrent).NCT02974621·La Jolla, California and 26 others

CompletedEarly Assessment and Intervention for Adolescents at Risk for Bipolar DisorderBipolar disorder is a severe and chronic illness associated with significant occupational and social impairment, enormous public health costs, and high rates of suicide.NCT03203707·Pittsburgh, Pennsylvania

Approved for marketingExpanded Access Study of Gilteritinib (ASP2215) in Patients With FMS-like Tyrosine Kinase 3 (FLT3) Mutated Relapsed or Refractory Acute Myeloid Leukemia (AML) or FLT3-Mutated AML in Complete Remission (CR) With Minimal Residual Disease (MRD)The purpose of this study is to provide expanded access to ASP2215 for subjects with FLT3-mutated relapsed or refractory AML or FLT3-mutated AML in composite complete remission…NCT03070093·Los Angeles, California and 38 others

CompletedZoledronic Acid for Osteoporotic Fracture Prevention (ZEST II)The goal of this study is to perform the first fracture reduction clinical trial with a potent antiresorptive agent (intravenous zoledronic acid) in the most vulnerable long-term…NCT02589600·New Kensington, Pennsylvania

Active not recruitingTesting the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in AdultsThis phase III trial compares the effect of usual treatment of chemotherapy and steroids and a tyrosine kinase inhibitor (TKI) to the same treatment plus blinatumomab.NCT04530565·Birmingham, Alabama and 210 others

WithdrawnPlacebo-controlled Proof of Concept Study of Epelsiban in Women With AdenomyosisThe primary objective of the study is to assess the efficacy, safety, and tolerability of epelsiban compared with placebo in treatment of women with adenomyosis.NCT02794467·Washington D.C., District of Columbia and 12 others

PreviousPage 275 of 536Next

Diabetes

in Pittsburgh

Heart Diseasein Pittsburgh